Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
作者信息
Deng Jian-Hao, Zhang Jia-Xing
机构信息
Pharmacy Department, Longyan Second Hospital, Longyan, China.
Pharmacy Department, Guizhou Provincial People's Hospital, Guiyang, China.
出版信息
Clin Cardiol. 2022 Jul;45(7):685-686. doi: 10.1002/clc.23851. Epub 2022 May 30.
Abstract
摘要
相似文献
1
Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.评论：非布司他与别嘌醇治疗痛风的心血管安全性比较：一项系统评价和荟萃分析。
Clin Cardiol. 2022 Jul;45(7):685-686. doi: 10.1002/clc.23851. Epub 2022 May 30.
2
The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.非布司他对比别嘌醇用于痛风或无症状高尿酸血症患者的净临床获益：一项系统评价和荟萃分析。
Nutr Metab Cardiovasc Dis. 2019 Oct;29(10):1011-1022. doi: 10.1016/j.numecd.2019.06.016. Epub 2019 Jun 24.
3
[Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)].痛风患者使用非布司他或别嘌醇：痛风合并心血管疾病患者中，非布司他和别嘌醇的心血管安全性（CARES研究）
Internist (Berl). 2020 May;61(5):530-532. doi: 10.1007/s00108-020-00766-4.
4
The major cardiovascular events of febuxostat versus allopurinol in treating gout or asymptomatic hyperuricemia: a systematic review and meta-analysis.非布司他与别嘌醇治疗痛风或无症状高尿酸血症的主要心血管事件：系统评价和荟萃分析。
Ann Palliat Med. 2021 Oct;10(10):10327-10337. doi: 10.21037/apm-21-1564. Epub 2021 Sep 6.
5
Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.非布司他与别嘌醇治疗痛风的心血管安全性比较：系统评价和荟萃分析。
Clin Cardiol. 2021 Jul;44(7):907-916. doi: 10.1002/clc.23643. Epub 2021 May 20.
6
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland.在先前对别嘌醇有反应后使用非布司他出现的皮肤不良事件：对辛格和克利夫兰文章的评论
Ann Rheum Dis. 2022 Jul;81(7):e124. doi: 10.1136/annrheumdis-2020-218226. Epub 2020 Jul 2.
7
Reply to comment on "Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis".对“非布司他与别嘌醇治疗痛风的心血管安全性：一项系统评价和荟萃分析”评论的回复
Clin Cardiol. 2022 Jul;45(7):687-690. doi: 10.1002/clc.23852. Epub 2022 May 30.
8
The efficacy of febuxostat and allopurinol in the treatment of gout with hyperuricemia.非布司他与别嘌醇治疗痛风伴高尿酸血症的疗效。
Pak J Pharm Sci. 2018 Jul;31(4(Special)):1623-1627.
9
Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials.不同剂量非布司他与别嘌醇治疗高尿酸血症的疗效和安全性：一项随机对照试验的荟萃分析。
BMC Pharmacol Toxicol. 2023 Dec 14;24(1):79. doi: 10.1186/s40360-023-00723-5.
10
A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.一项3期、多中心、随机、别嘌醇对照研究，评估口服非布司他在中国高尿酸血症痛风患者中的安全性和有效性。
Int J Rheum Dis. 2015 Jul;18(6):669-78. doi: 10.1111/1756-185X.12648. Epub 2015 May 27.
引用本文的文献
1
Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System.非布司他与别嘌醇的心血管安全性评估：来自美国食品药品监督管理局不良事件报告系统的结果
J Clin Med. 2023 Sep 20;12(18):6089. doi: 10.3390/jcm12186089.
本文引用的文献
1
Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.非布司他与别嘌醇治疗痛风的心血管安全性比较：系统评价和荟萃分析。
Clin Cardiol. 2021 Jul;44(7):907-916. doi: 10.1002/clc.23643. Epub 2021 May 20.
2
Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.亚洲人群中别嘌醇和非布司他治疗相关的超敏反应和心血管风险：一项基于人群的队列研究和荟萃分析。
Clin Pharmacol Ther. 2019 Aug;106(2):391-401. doi: 10.1002/cpt.1377. Epub 2019 Mar 20.
3
4
The levels of evidence and their role in evidence-based medicine.证据的级别及其在循证医学中的作用。
Plast Reconstr Surg. 2011 Jul;128(1):305-310. doi: 10.1097/PRS.0b013e318219c171.
5
Measuring inconsistency in meta-analyses.评估荟萃分析中的异质性
BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
Zotero 插件